Acadia Pharmaceuticals (ACAD) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.51% |
| Dec 31, 2025 | -11.43% |
| Sep 30, 2025 | -10.62% |
| Jun 30, 2025 | -3.96% |
| Mar 31, 2025 | 4.70% |
| Dec 31, 2024 | 11.00% |
| Sep 30, 2024 | -16.64% |
| Jun 30, 2024 | 18.93% |
| Mar 31, 2024 | 15.98% |
| Dec 31, 2023 | 6.96% |
| Sep 30, 2023 | 8.97% |
| Jun 30, 2023 | 7.79% |
| Mar 31, 2023 | 20.12% |
| Dec 31, 2022 | 10.59% |
| Sep 30, 2022 | 6.58% |
| Jun 30, 2022 | -0.56% |
| Mar 31, 2022 | 5.42% |
| Dec 31, 2021 | -2.06% |
| Sep 30, 2021 | -9.24% |
| Jun 30, 2021 | 15.17% |
| Mar 31, 2021 | 11.69% |
| Dec 31, 2020 | 26.13% |
| Sep 30, 2020 | 44.91% |
| Jun 30, 2020 | 27.20% |
| Mar 31, 2020 | 17.76% |
| Dec 31, 2019 | 25.12% |
| Sep 30, 2019 | 60.34% |
| Jun 30, 2019 | 40.29% |
| Mar 31, 2019 | 0.23% |
| Dec 31, 2018 | 63.01% |
| Sep 30, 2018 | 40.18% |
| Jun 30, 2018 | 25.06% |
| Mar 31, 2018 | 44.55% |
| Dec 31, 2017 | 3.70% |
| Sep 30, 2017 | 69.64% |
| Jun 30, 2017 | 73.27% |
| Mar 31, 2017 | 95.17% |
| Dec 31, 2016 | 88.42% |
| Sep 30, 2016 | 79.20% |
| Jun 30, 2016 | 75.04% |
| Mar 31, 2016 | 91.36% |
| Dec 31, 2015 | 71.68% |
| Sep 30, 2015 | 48.95% |